Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.
about
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationDepletion of serotonin and selective inhibition of 2B receptor suppressed tumor angiogenesis by inhibiting endothelial nitric oxide synthase and extracellular signal-regulated kinase 1/2 phosphorylationDinosaurs and ancient civilizations: reflections on the treatment of cancerThe use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival.Neoplasia: the second decade.Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progression.The effect of erythropoietin on normal and neoplastic cells.Erythropoietin and cancer: the unintended consequences of anemia correctionEpo receptors are not detectable in primary human tumor tissue samplesEpoetin beta for the treatment of chemotherapy-induced anemia: an update.Erythropoietin improves the accumulation and therapeutic effects of carboplatin by enhancing tumor vascularization and perfusionErythropoietin Stimulates Tumor Growth via EphB4.Erythropoietin promotes the growth of pituitary adenomas by enhancing angiogenesis.Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibodyRecombinant human epoetin beta in the treatment of chemotherapy-related anemia.Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response.Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.The War on Cancer rages on.Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.Predictive mathematical models of cancer signalling pathways.In-vivo detection of the erythropoietin receptor in tumours using positron emission tomography.Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.Erythropoietin and Its Angiogenic Activity.Erythropoietin receptor contributes to melanoma cell survival in vivo.Erythropoietin increases macrophage-mediated T cell suppression.An unusual case of malignant thymoma associated graft-versus-host diseaseErythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma.Long-term moderate dose exogenous erythropoietin treatment protects from intermittent hypoxia-induced spatial learning deficits and hippocampal oxidative stress in young rats.Epo is involved in angiogenesis in human glioma.Royal jelly prevents the progression of sarcopenia in aged mice in vivo and in vitro.Role of Erythropoietin and Other Growth Factors inEx VivoErythropoiesis
P2860
Q24306910-79F6B3B5-A4DA-4CA4-B7BF-585383632408Q24309173-1E35F06A-3B0D-4DE1-B5DB-0058BEE39306Q24628746-AE0C247F-0621-44C1-A48A-0DBD39946566Q30453014-3FF11AA3-F75D-4A0A-AE90-91C933982C27Q30484000-68734108-419A-4752-8C68-FFE986FDFFD4Q33920934-024A7288-93C9-4E2F-A6F0-FE8978680156Q34291437-60ED463F-94F7-4C52-847B-C577C8DD4E0AQ34488415-0EDAE986-8701-4FD0-89BF-AED14116339AQ34826770-EA59EDD9-CA47-4F97-B8C1-23666F31705FQ35168681-3F145EDE-BD9A-4D2C-BF7A-FA1C3B129DF8Q35633372-E04FC6EE-8646-46EA-ADC2-4F44415FB91FQ36275814-970C2FD6-4A71-406B-BD67-C924B194F8CBQ36645651-A9D8DD4A-C0C3-4169-9502-4FA8EC47E13EQ37046655-FD53D699-1407-4FCC-9B66-1BC719FA5ED8Q37107771-94EC46C2-719D-4FF5-886F-B8D5FF5E8DD6Q37230276-BC4EC2B6-F021-40A5-8E7B-3C945F0FC3E2Q37328549-C9C290D0-54CE-44E4-A6A3-DB366E2A49C1Q37351764-318D2D9C-2D8D-4AE0-9332-2A8602684645Q37478602-3B0AD588-A674-44C5-9A6D-C997FFD9C7C9Q37524229-B6FBAD05-1118-4965-98D6-D4DF64A0B339Q37964775-F5FF0FDF-89AF-4829-81AA-F14D89B0D1FBQ38958980-5003CDC5-E27D-4DC8-99CB-58F10A4A8B6BQ39372905-CA579842-E145-40FB-B9FF-52C71858F300Q39432541-DA12D8C6-06B6-4AE5-8B71-EDC930EAD9A8Q39486076-C4FB610F-9784-448E-850F-4639858901F5Q41807007-61FE4696-6511-4DF0-91AF-783ECDBE9375Q42266863-3EA6D5C4-8DCC-47AD-A1DA-0496CEE139B5Q44034165-53DCD240-70D3-4242-8545-41D599980F06Q45976217-992D45A9-7CC7-4D21-94B7-BB3478B9BFC1Q48135959-9B76C239-DD3C-4D40-B385-5B8C1F68E6F5Q51009131-D4CFA58A-CD4F-43E0-BA19-7A45F3DAC450Q59051222-FA90F340-723B-4ECA-91BE-23041413EE31
P2860
Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.
@en
type
label
Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.
@en
prefLabel
Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.
@en
P2093
P2860
P356
P1433
P1476
Erythropoietin promotes the gr ...... ice by enhancing angiogenesis.
@en
P2093
Hiroyuki Arai
Kaijun Niu
Masanori Asada
Satoru Ebihara
Shinsuke Yamanda
Tatsuma Okazaki
P2860
P304
P356
10.1593/NEO.08140
P577
2008-09-01T00:00:00Z